Q1 EPS Estimates for Krystal Biotech Decreased by Analyst
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Research analysts at William Blair cut their Q1 2025 EPS estimates for shares of Krystal Biotech in a note issued to investors on Wednesday, April 2nd. William Blair analyst S. Corwin now anticipates that the company will post earnings per share of $1.31 for the quarter, down […]
